SERTRALINE Safety Questions, SERTRALINE Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about SERTRALINE. Our extensive database of SERTRALINE adverse events and SERTRALINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about SERTRALINE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




SERTRALINE Safety Reports

Total SERTRALINE reports: 538.
SERTRALINE FDA safety alerts: 2002 2003 2004 2005 .
Reported deaths: 74    Reported hospitalizations: 118.
Take SERTRALINE Side Effects Survey or Share Your SERTRALINE Story. Read More Here.

Showing 1-75 of 538 Next >

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Feb 23, 2007. Male patient, 47 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: circulatory collapse. SERTRALINE dosage: 200 MG (200 MG, 1 IN 1 D) ??. Patient died.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 23, 2007. Male patient, 47 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: circulatory collapse. SERTRALINE dosage: 200 MG. Patient died.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Mar 12, 2007. Female patient, weighting 110.0 lb, was diagnosed with major depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression, suicidal ideation, weight decreased. SERTRALINE dosage: unknown. During the same period patient was treated with WELLBUTRIN, KLONAPIN, TOPAMAX. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 15 years of age, weighting 144.0 lb, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, agitation, anxiety, dizziness, fatigue, influenza like illness, insomnia, irritability. SERTRALINE dosage: 50MG DAILY PO. Patient recovered.

Consumer or non-health professional from MALAYSIA reported SERTRALINE problem on Feb 27, 2007. Female patient, 31 years of age, was diagnosed with depression, anxiety, convulsion and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, hyperventilation, hypoaesthesia, insomnia, paraesthesia, tremor. SERTRALINE dosage: 50 MG, QD, ORAL. During the same period patient was treated with VALPROATE. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from MALAYSIA on Feb 27, 2007. Female patient, 15 years of age, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: muscle spasticity. SERTRALINE dosage: 50 MG, QD, ORAL. During the same period patient was treated with HALOPERIDOL. Patient recovered.

Pharmacist from UNITED STATES reported SERTRALINE problem on Mar 12, 2007. Male patient, 81 years of age, weighting 218.0 lb, was diagnosed with depression, myocardial ischaemia and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: bradycardia, dizziness postural, hypotension. SERTRALINE dosage: 100MG DAILY PO. During the same period patient was treated with METOPROLOL SUCCINATE, FLOMAX, DITROPAN, LISINOPRIL, PLAVIX, NITROGLYCERIN, ASPIRIN, LOVASTATIN. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Physician from UNITED STATES on Mar 13, 2007. Female patient, weighting 141.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: dizziness, fatigue, headache. SERTRALINE dosage: 100MG 1 DAILY PO. Patient recovered.

Consumer or non-health professional from European Union reported SERTRALINE problem on Mar 05, 2007. Male patient, 47 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: fall, loss of consciousness. SERTRALINE dosage: 200 MG QD. Patient died.

SERTRALINE problem was reported by a Pharmacist from UNITED STATES on Mar 15, 2007. Male patient, weighting 200.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: irritability. SERTRALINE dosage: 100MG TABLET. During the same period patient was treated with NEFAZADONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Mar 16, 2007. Female patient, weighting 184.0 lb, was diagnosed with postpartum depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, depression, suicidal ideation. SERTRALINE dosage: 100MG 2 TABS ONCE A DAY PO. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Physician from TURKEY on Mar 05, 2007. Female patient, 46 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: corneal erosion, diplopia, dry eye, eye disorder, halo vision, mydriasis, scar, vision blurred, visual disturbance. SERTRALINE dosage: unknown. During the same period patient was treated with ALPRAZOLAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from MALAYSIA reported SERTRALINE problem on Mar 06, 2007. Female patient was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: cleft lip and palate. SERTRALINE dosage: unknown. During the same period patient was treated with LORAZEPAM. Patient recovered.

SERTRALINE problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Male patient, weighting 210.0 lb, was diagnosed with major depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, depression, dizziness, nausea. SERTRALINE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported SERTRALINE problem on Mar 17, 2007. Female patient, child 12 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: blood triglycerides increased. SERTRALINE dosage: unknown. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Female patient, 38 years of age, weighting 165.0 lb, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anxiety, disease recurrence, dyspepsia, dysphagia, hyperhidrosis, nausea, panic attack. SERTRALINE dosage: 100 MG PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Mar 22, 2007. Female patient, weighting 220.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: anxiety, emotional disorder, impaired work ability, initial insomnia, mood altered, social avoidant behaviour. SERTRALINE dosage: 100MG ONE PER DAY PO. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from GERMANY on Mar 15, 2007. Female patient was diagnosed with depression, convulsion and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: delusion of replacement, grand mal convulsion, psychotic disorder. SERTRALINE dosage: DAILY DOSE:50MG. During the same period patient was treated with PHENYTOIN, PHENOBARBITAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported SERTRALINE problem on Mar 26, 2007. Male patient, 47 years of age, weighting 160.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: dizziness, eating disorder, gait disturbance, gastroenteritis viral, nausea, treatment noncompliance, vertigo, vomiting. SERTRALINE dosage: 1/2 TABLET -50 MG- DAILY PO. Patient recovered.

SERTRALINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 22, 2007. Male patient, child 12 years of age, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: diverticulum. SERTRALINE dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported SERTRALINE problem on Mar 23, 2007. Male patient, 64 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: asthenia, balance disorder, confusional state, convulsion, muscle twitching. SERTRALINE dosage: unknown. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Male patient, 50 years of age, weighting 185.0 lb, was diagnosed with depression, insomnia, stress and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, confusional state, diarrhoea, hyperhidrosis, insomnia, mood altered, suicidal ideation, tremor. SERTRALINE dosage: 25MG 1X PER DAY PO. Patient died on 03/22/2007.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Mar 29, 2007. Female patient, weighting 160.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, dizziness, headache, panic attack, suicidal ideation. SERTRALINE dosage: 100 MG 1 TABLET DAILY PO. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 19, 2007. Male patient, child 12 years of age, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression, emotional disorder, insomnia, lethargy, tic. SERTRALINE dosage: 25 MG ONCE DAILY - TAKEN AT NIGHT (1/ 1DAYS), ORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Mar 30, 2007. Female patient, 57 years of age, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: constipation, oedema, oedema peripheral. SERTRALINE dosage: 50MG DAILY. Patient recovered.

SERTRALINE problem was reported by a Health Professional from BRAZIL on Mar 16, 2007. Male patient, 16 years of age, was diagnosed with major depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: disease progression, epilepsy. SERTRALINE dosage: 50 MG/DAY,. During the same period patient was treated with VALPROIC ACID, LAMOTRIGINE, PHENOBARBITAL. Patient recovered.

Health Professional from BRAZIL reported SERTRALINE problem on Mar 16, 2007. Male patient, 13 years of age, was diagnosed with major depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, epilepsy. SERTRALINE dosage: 50 MG/DAY,. During the same period patient was treated with CARBAMAZEPINE. Patient recovered.

SERTRALINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 19, 2007. Male patient, child 12 years of age, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression, emotional disorder, insomnia, lethargy, tic. SERTRALINE dosage: 25 MG, QD, ORAL. Patient recovered.

Consumer or non-health professional from reported SERTRALINE problem on Mar 28, 2007. Female patient, 36 years of age, was diagnosed with contraception and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, rhabdomyolysis. SERTRALINE dosage: unknown. During the same period patient was treated with ASPIRIN, EPHEDRINE SUL CAP, MEDROXYPROGESTERONE ACETATE, ASCORBIC ACID, VITAMIN E, CAFFEINE, B VITAMIN PLE, CALCIUM. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 26, 2007. Female patient, 49 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: hepatic encephalopathy. SERTRALINE dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, RISPERIDONE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported SERTRALINE problem on Apr 02, 2007. Female patient, weighting 142.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression. SERTRALINE dosage: 50MG 1 1/2 QD PO. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from CANADA on Mar 28, 2007. Female patient, 36 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, rhabdomyolysis. SERTRALINE dosage: DAILY DOSE:125MG. During the same period patient was treated with MEDROXYPROGESTERONE, EPHEDRINE SUL CAP, ACETYLSALICYLIC ACID SRT, CAFFEINE, VITAMIN CAP, ASCORBIC ACID, VITAMIN E, CALCIUM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported SERTRALINE problem on Apr 06, 2007. Female patient, 21 years of age, weighting 120.0 lb, was diagnosed with obsessive-compulsive disorder and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression, intentional self-injury, mood altered, no therapeutic response, suicidal ideation. SERTRALINE dosage: 50MG 1 DAILY PO. Patient recovered.

SERTRALINE problem was reported by a Health Professional from UNITED KINGDOM on Apr 03, 2007. Male patient, child 12 years of age, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression, diverticulum, emotional disorder, hyperphagia, insomnia, lethargy. SERTRALINE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Mar 23, 2007. Male patient, 64 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: balance disorder, confusional state, convulsion, muscle twitching, muscular weakness, transient ischaemic attack. SERTRALINE dosage: 50 MG, ORAL. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 23, 2007. Male patient, 64 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: asthenia, balance disorder, confusional state, convulsion, muscle twitching, transient ischaemic attack. SERTRALINE dosage: ^50 MG, REDUCED TO AT LEAST 2/12 25 MG AND WIL NOW STOP NEXT 3/52^ ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Mar 26, 2007. Female patient, 49 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: brain oedema, csf glucose decreased, haemodialysis, hepatic encephalopathy, laboratory test abnormal, pulmonary oedema, urine output decreased. SERTRALINE dosage: unknown. During the same period patient was treated with RISPERIDONE, PARACETAMOL. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2007. Male patient, 60 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: multi-organ failure. SERTRALINE dosage: unknown. During the same period patient was treated with TRAZODONE, COCAINE, PARACETAMOL, FENTANYL. Patient died on 08/30/2006.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Apr 09, 2007. Female patient, 31 years of age, weighting 105.0 lb, was diagnosed with depression, panic disorder with agoraphobia and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: anxiety, fatigue, lethargy, nasopharyngitis, panic disorder, rash, somnolence. SERTRALINE dosage: unknown. During the same period patient was treated with SERTRALINE HCI. Patient recovered.

SERTRALINE problem was reported by a Pharmacist from UNITED STATES on Apr 09, 2007. Female patient was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: stomatitis, tongue disorder. SERTRALINE dosage: 150MG DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Apr 10, 2007. Male patient, 62 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: vomiting. SERTRALINE dosage: unknown. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from AUSTRIA on Mar 12, 2007. Male patient, 22 years of age, was diagnosed with schizophrenia and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: asthenia, depressed mood, priapism. SERTRALINE dosage: 50,000 MG (50 MG, 1 IN 1 D). During the same period patient was treated with RISPERIDONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Apr 12, 2007. Female patient, 40 years of age, weighting 168.0 lb, was diagnosed with premenstrual syndrome and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: crying, depressed mood, irritability. SERTRALINE dosage: 25 MG 1X A DAY PO. Patient recovered.

SERTRALINE problem was reported by a Physician from UNITED STATES on Apr 11, 2007. Female patient, 41 years of age, was diagnosed with major depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastric disorder, nausea, suicidal ideation. SERTRALINE dosage: 150 MG QD. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Mar 30, 2007. Female patient, 49 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: dialysis, hepatic encephalopathy, laboratory test abnormal, pulmonary oedema, urine output decreased. SERTRALINE dosage: unknown. During the same period patient was treated with PARACETAMOL, RISPERIDONE. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 61 years of age, weighting 155.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: anxiety, condition aggravated, depression. SERTRALINE dosage: 100 MG DAILY. Patient recovered.

Physician from UNITED STATES reported SERTRALINE problem on Apr 13, 2007. Male patient, 53 years of age, weighting 144.0 lb, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dysarthria. SERTRALINE dosage: 100MG 1 QD. Patient recovered.

SERTRALINE problem was reported by a Pharmacist from UNITED STATES on Apr 13, 2007. Male patient was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: nausea, paraesthesia, vomiting. SERTRALINE dosage: 100 MG ONCE DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Apr 12, 2007. Male patient, 74 years of age, was diagnosed with anxiety, depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: agitation, homicide, suicidal ideation. SERTRALINE dosage: unknown. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 03, 2007. Male patient, child 12 years of age, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression, emotional disorder, hyperphagia, insomnia, lethargy, tic. SERTRALINE dosage: 25 MG ONCE DAILY - TAKEN AT NIGHT ORAL. Patient recovered.

Health Professional from UNITED KINGDOM reported SERTRALINE problem on Mar 22, 2007. Male patient, child 12 years of age, was diagnosed with anxiety and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: depression, emotional disorder, hyperphagia, insomnia, lethargy, tic. SERTRALINE dosage: 25 MG, QD, ORAL. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from on Apr 18, 2007. Male patient, 72 years of age, was diagnosed with pain, rash and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, cough, dyspnoea, fatigue. SERTRALINE dosage: unknown. During the same period patient was treated with RABEPRAZOLE, ACETAMINOPHEN W, PREDNISONE, BETAMETHASONE VALERATE, COLESTIPOL, FUROSEMIDE, METOPROLOL SUCCINATE, NITROGLYCERIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported SERTRALINE problem on Apr 10, 2007. Female patient, 36 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, rhabdomyolysis. SERTRALINE dosage: DAILY DOSE:125MG. During the same period patient was treated with MEDROXYPROGESTERONE, EPHEDRINE SUL CAP, ASPIRIN, VITAMIN E, CAFFEINE, VITAMIN B CAP, ASCORBIC ACID, CALCIUM. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Physician from UNITED STATES on Apr 17, 2007. Female patient, weighting 148.0 lb, was diagnosed with anxiety, depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: mental disorder. SERTRALINE dosage: 100MG 1 TABLET DAILY PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Apr 18, 2007. Female patient, weighting 151.0 lb, was diagnosed with depression, premenstrual syndrome and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: anxiety, confusional state, depression, diarrhoea, gastrooesophageal reflux disease, headache, irritability. SERTRALINE dosage: unknown. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Female patient, 34 years of age, weighting 190.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. SERTRALINE dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported SERTRALINE problem on Apr 13, 2007. Female patient, 49 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, brain oedema, csf glucose decreased, gamma-glutamyltransferase increased, hepatic encephalopathy, intentional overdose, oliguria, pulmonary oedema. SERTRALINE dosage: unknown. During the same period patient was treated with PARACETAMOL, RISPERDAL. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Health Professional from UNITED KINGDOM on Apr 13, 2007. Female patient, 31 years of age, was diagnosed with panic disorder, suicidal ideation, depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: agitation, depression, homicide, restlessness, suicidal ideation, suicide attempt, tension. SERTRALINE dosage: unknown. During the same period patient was treated with PAROXETINE, ALPRAZOLAM. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Apr 13, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: ileus paralytic. SERTRALINE dosage: unknown. During the same period patient was treated with CLOZAPINE. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, 69 years of age, was diagnosed with depression, pain and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: mental status changes, mutism, myoclonus, nausea, pyrexia, serotonin syndrome, vomiting. SERTRALINE dosage: DAILY DOSE:50MG. During the same period patient was treated with METHADONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Apr 17, 2007. Female patient, 49 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, brain oedema, csf glucose decreased, haemodialysis, hepatic encephalopathy, pulmonary oedema. SERTRALINE dosage: unknown. During the same period patient was treated with PARACETAMOL, RISPERDAL. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 16, 2007. Male patient, child 12 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, hallucination, homicide, mania, psychotic disorder, refusal of treatment by relative, restlessness. SERTRALINE dosage: unknown. During the same period patient was treated with PAROXETINE. Patient recovered.

Physician from UNITED STATES reported SERTRALINE problem on Apr 25, 2007. Female patient was diagnosed with depression, panic disorder and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: disease recurrence, gastrointestinal disorder, headache, night sweats, panic disorder, tachycardia. SERTRALINE dosage: 50 MG. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2007. Female patient, 36 years of age, weighting 138.2 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pharyngeal oedema, throat tightness. SERTRALINE dosage: 50 MG, QD, ORAL. During the same period patient was treated with ALCOHOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Apr 18, 2007. Male patient, 72 years of age, was diagnosed with pain, rash and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, cough, dyspnoea, fatigue. SERTRALINE dosage: DAILY DOSE:50MG. During the same period patient was treated with RABEPRAZOLE, ACETAMINOPHEN W, PREDNISONE, BETAMETHASONE VALERATE, COLESTIPOL HYDROCHLORIDE, FUROSEMIDE, METOPROLOL SUCCINATE, NITROGLYCERIN. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 18, 2007. Female patient, 49 years of age, was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: hepatic encephalopathy. SERTRALINE dosage: unknown. During the same period patient was treated with PARACETAMOL, RISPERIDONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported SERTRALINE problem on Apr 25, 2007. Male patient, 22 years of age, was diagnosed with depressed mood, asthenia, depressive symptom, schizophrenia and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: erection increased, priapism. SERTRALINE dosage: unknown. During the same period patient was treated with RISPERIDONE. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 13, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: eructation, ileus paralytic. SERTRALINE dosage: unknown. During the same period patient was treated with CLOZAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Apr 11, 2007. Female patient, 36 years of age, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: alcohol use, dyspnoea, pharyngeal oedema, throat tightness. SERTRALINE dosage: 50 MG (1/1 DAYS) ORAL. Patient was hospitalized. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 13, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, eructation, flatulence, ileus paralytic, vitello-intestinal duct remnant. SERTRALINE dosage: unknown. During the same period patient was treated with CLOZAPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported SERTRALINE problem on Apr 12, 2007. Male patient, 74 years of age, was diagnosed with anxiety, depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: agitation, feeling abnormal, homicide, incorrect dose administered, suicidal ideation. SERTRALINE dosage: unknown. Patient recovered.

SERTRALINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 11, 2007. Female patient, 36 years of age, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: alcohol use, dyspnoea, pharyngeal oedema, throat tightness. SERTRALINE dosage: 50 MG; QD. During the same period patient was treated with ALCOHOL. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported SERTRALINE problem on Apr 17, 2007. Male patient, 59 years of age, weighting 194.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: burning sensation, dyspnoea, epiglottitis, foreign body trauma, pharyngitis, pyrexia, throat irritation, vocal cord inflammation. SERTRALINE dosage: 50 MG, QD, ORAL. During the same period patient was treated with PLAVIX, COVERSYL, PROSCAR, INEGY, OMIX. Patient recovered.

SERTRALINE problem was reported by a Health Professional from UNITED KINGDOM on Apr 12, 2007. Male patient, 74 years of age, was diagnosed with anxiety, depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: agitation, akathisia, delirium, feeling abnormal, homicide, incorrect dose administered, suicidal ideation. SERTRALINE dosage: 50 MG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported SERTRALINE problem on Apr 30, 2007. Female patient, weighting 168.0 lb, was diagnosed with depression and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: anxiety, condition aggravated, depression, suicidal ideation. SERTRALINE dosage: unknown. Patient recovered.

Showing 1-75 of 538 Next >

Ask Our Patient Community about SERTRALINE

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)